Company profile

Tribvn

Pathology & Laboratory Diagnostics

Company profile

About Tribvn

Tribun Health is a leading provider of AI-powered digital pathology solutions dedicated to modernizing pathology diagnostics worldwide. The company offers an award-winning, end-to-end digital pathology platform that encompasses image acquisition, storage, viewing, AI-powered analysis, and remote case sharing. At the core of their offering is CaloPix®, a web-based Image Management System that has been recognized as Best in KLAS for Digital Pathology in Europe for three consecutive years (2022-2024) and continues to rank among the top 3 solutions globally. The platform includes five integrated modules: MacroCam for macroscopic image capture, CaloPix® for image management and visualization, CaloPix® Archive for data management, AI Apps for intelligent image analysis, and TeleSlide® for remote case sharing and collaboration. Tribun Health serves both diagnostic laboratories and pharmaceutical companies, with over 100 customers including diagnostic and pharma labs across Western Europe and North America. The company's solutions are designed to address the challenges of dwindling medical resources and escalating specialization by providing quick access to expert diagnoses through digitization. With over 15 years of pathology experience and a team of more than 50 specialists, Tribun Health is committed to improving cancer diagnosis through innovation, collaboration, and user-centric design. Their platform is CE-marked, approved by Health Canada as a medical device, and features agnostic architecture that integrates seamlessly with various LIS systems, WSI scanners, storage solutions, and AI algorithms.

Company description Tribvn official website

Primary marketPathology & Laboratory Diagnostics
Commercial modelCommercial information available on request
Company presenceOfficial website
Work at Tribvn?

Claim this profile to manage Company information and connect with the Health AI Central audience.

Claim this listing

01 · Operating footprint

Where the Company operates

Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.

Clinical focus

  • Cancer diagnostics
  • Pathology diagnostics

Who it serves

  • Academic medical centers
  • CROs
  • Diagnostic laboratories
  • Hospital networks
  • Pharmaceutical companies
  • Regional health systems

Deployment & integration

Api Only · Cloud Saas · Hybrid · On Premise deployment with recorded integration context.

Recorded integration context: AWS, Electronic Health Record (EHR), Laboratory Information System (LIS), Microsoft Azure, WSI scanners.

Geographic context

MarketsExpanding into new markets globally · North America · Western Europe
Company sourceOfficial website

Company milestones

Platform expansion

Ranked among top 3 in Digital Pathology by KLAS in 2025 and 2026, following Best in KLAS awards 2022-2024. Deployed across academic centers, regional networks, and national health systems. Over 100 customers including diagnostic and pharma labs.

Partnerships

Recorded partners

  • AWS
  • KLAS Research
  • Microsoft Azure
  • Multiple AI algorithm partners

02 · Flagship portfolio

Products, workflows, and platform capabilities

Selected source-backed Company products and the available commercial context.

AI Apps

Comprehensive catalog of AI algorithms for pathology workflow optimization and diagnosis

Software · Api OnlyCompany source

CaloPix®

Web-based Image Management System for digital pathology slide management and analysis

Platform · Cloud SaaSCompany source

CaloPix® Archive

Flexible data management solution for digital pathology slide storage and archiving

Software · HybridCompany source

MacroCam

High-quality macroscopic image capture system for pathology specimens

Device · On PremiseCompany source

TeleSlide® Patho

Remote case sharing platform for pathology second opinions and collaboration

Platform · Cloud SaaSCompany source

03 · Research intelligence

Research Intelligence evidence

Publications, preprints, clinical validation, and regulatory records in Evidence Position order.

Evidence position

Publications, clinical validation, and regulatory records connected to this Company appear here.

Research

Publications & preprints

No linked records are currently available.

Clinical validation

Clinical-trial records

No linked records are currently available.

Regulatory

Regulatory records

No linked records are currently available.

04 · Company-reported outcomes

Outcomes and case studies

Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.

Up to 30% reduction in slide weight

Through reversible sub-resolution removal action

Up to 40x infrastructure savings

With efficient hot and cold archiving solutions

Improved diagnostic speed and quality

Through digital transformation of pathology workflows

GHU APHP Nord (AP-HP)

Enterprise-wide image management system implementation for APHP hospitals to enhance patient diagnosis quality and speed

Enhanced patient diagnosis in terms of quality and speed

Paris Saclay Hospital Group

Integration of digital pathology for routine diagnosis to improve laboratory performance and reduce costs

Increased productivity, elimination of time-consuming tasks, improvement in laboratory performance, and cost reduction

05 · Leadership

Leadership team

Leadership profiles and professional links from the current Company record.

Jean-François Pomerol

CEO

06 · Company updates

Updates from Tribvn

Recent articles published on Tribvn's official website.

07 · HAIC coverage

Coverage and analysis

Health AI Central reporting that mentions this Company.

No HAIC coverage is currently linked to this Company.

08 · Official presence

Company sources and channels

Curated official destinations from the active Company record.

09 · Market pathway

Additional Companies in this Market

Other active Companies in the same market, selected alphabetically from the HAIC directory.

Market context

Pathology & Laboratory Diagnostics

Companies applying AI to digital pathology, histopathology slide analysis, laboratory diagnostics, or biomarker discovery. Includes AI-powered interpretation of lab test results, at-home diagnostic devices with AI analysis, and platforms that analyze tissue samples or biological specimens to support clinical diagnosis.

Explore the full market directory or compare this Company with additional active profiles.

View all Companies in this market

10 · Pro research

Coming soon

Expanded Company research is in development.

Health AI Central Pro · Coming Soon

Deeper Company research is coming soon.

Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.

ResearchEvidence analysis

Linked research, clinical, and regulatory source pathways.

CompanyTechnical context

Expanded product, deployment, integration, and partnership research.

MethodSource & review record

Record-level provenance and review context.

Coming Soon